Mouthwash showdown: new formula takes on classic antiseptic for healthier gums
NCT ID NCT07088653
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two mouthwashes—a standard antiseptic (chlorhexidine) and a new one (MicroRepair ABX)—in 40 adults with gingivitis (gum inflammation). After a professional cleaning, participants used their assigned mouthwash twice daily for 14 days. Researchers measured gum bleeding, plaque buildup, and a saliva marker of inflammation over 6 months to see if the new mouthwash works as well as the standard one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENTAL PLAQUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can smoking alter blood vessel proteins in your gums?
- Can special alloy rings keep dental implants cleaner?
- Can gum disease be stopped by targeting these genes?
- Could Stressed-Out gum cells be behind periodontitis?
- Can genes explain why some gums flare up faster?
- Mouth proteins may hold clues to gum disease severity